A new study led by the University of Toronto (U of T) has discovered a possible biomarker linked to multiple sclerosis (MS) ...

Researchers are continuing to explore how the CXCL13-to-BAFF ratio can be used to advance precision medicine for people with multiple sclerosis.

The country music world was heartbroken by the recent news that Raul Malo, the frontman for The Mavericks, has died. Malo, ...

Phase 1 data presented by Andrew Brenner, MD, PhD, showed RNL-186 improved survival, reduced symptoms, and demonstrated strong safety in patients with leptomeningeal metastases. New findings from a ...

Raul Malo is tough and his fight against cancer has been both brutal and beautiful. The brutal parts, of course, have come via the twists and unforgiving turns that the disease can dole out. The ...

Secondary CNS involvement in CLL/SLL was rare at 1.1% to 1.7% across 15 years. Secondary central nervous system (CNS) involvement in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) ...

"The Phase IIa results provide important early clinical signals that reinforce the potential of QBS72S to meaningfully impact outcomes for patients with LMD," said Gordon Ringold, Ph.D., CEO of ...

Leptomeningeal disease (LMD) is a rare metastatic complication with a grim prognosis for most patients and limited treatment strategies. Therapy is adjusted to the primary tumor from which it arises.

Researchers at Moffitt Cancer Center have reported encouraging results from a phase 1B clinical trial showing that the immunotherapy drug avelumab, when combined with whole brain radiotherapy, may ...

TAMPA, Fla. (Sept. 30, 2025) — Researchers at Moffitt Cancer Center have reported encouraging results from a phase 1B clinical trial showing that the immunotherapy drug avelumab, when combined with ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...